Chemaxon blog
Filter by content type
Certara Completes Acquisition of Chemaxon
The combined organization offers life sciences companies predictive biosimulation and scientific...
euroSAMPL1 blind prediction challenge with Chemaxon's Calculators and Predictors
euroSAMPL1 blind prediction challenge - using calculators and predictors by Chemaxon
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
We are excited to share the official announcement of Certara, our partner for over a decade, as...
Ending the game of cat and mouse: The rise of structure-based generic definitions in Controlled Compound Legislation
Discover how the surge in generic drug legislation complicates identification of controlled...
Pharma use case with Design Hub: Digital workflow support for compound design
Design Hub case study - use case with a renowned German pharmaceutical company.
Lunch and Learn 2024
Join our India Lunch and Learn events with presentations and Chemaxon product demos in May.
ChemTalks 2024
ChemTalks is asking the question: how can technology bridge silos within drug discovery? Join us...
Discovery Europe 2024
Join us at the Discovery Europe event in Basel, Switzerland and engage with our experts about...
Roadblocks of DMTA project success - and how to eliminate them
Discover how to navigate complex challenges in your DMTA projects - make informed compound...
"Make the company look like I won the lottery"
This article was originally published in Hungarian, in November 2023. Visit Publication Chemaxon...
Overcoming Medicinal Chemists’ Reluctance to Use AI/ML Tools
AI/ML tools in drug discovery, concerns about data quality and availability, interpretability of...
DMTA lead optimization: Where science meets project management
From hit identification to optimized leads; explore how effective project management techniques can...